Abstract
INTRODUCTION:Despite effective dietary treatments, physicians prefer medications for eosinophilic esophagitis (EoE).METHODS:We conducted a web-based survey of providers to assess the perceived effectiveness, practice patterns, and barriers to EoE dietary therapy.RESULTS:Providers view diet as the least effective treatment. The greatest barrier was the belief that patients are disinterested and unlikely to adhere (58%). With less access to dietitians (56%), nonacademic providers often manage diets without dietitian guidance (41%).DISCUSSION:Given high patient acceptance for diets and multiple treatment options for EoE, clinicians need evidence-based knowledge on EoE diets, access to dietitians, and awareness of patient preferences.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2071-2074 |
| Number of pages | 4 |
| Journal | American Journal of Gastroenterology |
| Volume | 117 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1 2022 |
Funding
Financial support: J.W.C. is supported by funding in part by NIH award K23DK129784 and a training grant from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (U54AI117804). This work was supported by U54AI117804 (CEGIR), which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR). CEGIR is also supported by patient advocacy groups including American Partnership for Eosinophilic Disorders (APFED), Campaign Urging Research for Eosinophilic Diseases (CURED), and Eosinophilic Family Coalition (EFC). As a member of the RDCRN, CEGIR is also supported by its Data Management and Coordinating Center (DMCC) (U2CTR002818).
ASJC Scopus subject areas
- Gastroenterology
- Hepatology